URGN analyst estimates
UroGen Pharma (URGN) analyst ratings, the average price target and its range, and every firm's latest call.
URGN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 10, 2026 | Jefferies | Jefferies Reiterates Buy Rating on UroGen Pharma (URGN) | $56.00 |
| Aug 6, 2026 | H.C. Wainwright | UroGen Pharma price target raised to $75 from $45 at H.C. Wainwright | $75.00 |
| Aug 6, 2026 | Guggenheim | UroGen Pharma price target raised to $58 from $42 at Guggenheim | $58.00 |
| Jul 21, 2026 | Guggenheim | UroGen Pharma price target raised to $42 from $32 at Guggenheim | $42.00 |
| Jul 16, 2026 | Oppenheimer | UroGen Pharma (URGN) PT Raised to $50 at Oppenheimer | $50.00 |
| Jul 15, 2026 | Goldman Sachs | UroGen Pharma price target raised to $44 from $18 at Goldman Sachs | $44.00 |
| May 11, 2026 | H.C. Wainwright | UroGen Pharma price target raised to $45 from $40 at H.C. Wainwright | $45.00 |
| Apr 9, 2026 | Jefferies | UroGen Pharma initiated with a Buy at Jefferies | $40.00 |
| Jun 13, 2025 | Oppenheimer | UroGen Pharma price target raised to $31 from $10 at Oppenheimer | $31.00 |
| Jun 13, 2025 | Goldman Sachs | UroGen Pharma price target raised to $16 from $3 at Goldman Sachs | $16.00 |
| Oct 14, 2024 | EF Hutton | EF Hutton Starts UroGen Pharma (URGN) at Buy | $25.00 |
| Jun 14, 2024 | Goldman Sachs | Goldman Sachs Reiterates Neutral Rating on UroGen Pharma (URGN) | $22.00 |
| Jun 14, 2024 | H.C. Wainwright | UroGen Pharma price target raised to $60 from $54 at H.C. Wainwright | $60.00 |
| Jun 14, 2024 | Oppenheimer | UroGen Pharma price target raised to $40 from $32 at Oppenheimer | $40.00 |
| Jun 14, 2024 | Evercore ISI | Hasbro To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday | $46.00 |
- 5 firms rate URGN: 5 buy, 0 hold, 0 sell.
- The average price target is $56.60 from 5 analysts, from $44.00 to $75.00.
Updated 2026-11-03 00:51 UTC